{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:25Z","timestamp":1786985005220,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601044"],"award-info":[{"award-number":["81601044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571596"],"award-info":[{"award-number":["81571596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371372"],"award-info":[{"award-number":["81371372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bbi.2017.04.023","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T02:15:22Z","timestamp":1493691322000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes"],"prefix":"10.1016","volume":"65","author":[{"given":"Zhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Thome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0555-6203","authenticated-orcid":false,"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2017.04.023_b0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","article-title":"Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG","volume":"127","author":"Asavapanumas","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2017.04.023_b0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.160.2.411","article-title":"Sexual dimorphism of the fifth component of mouse complement","volume":"160","author":"Baba","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2017.04.023_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/physzool.20.4.30151969","article-title":"The effect of male hormone on aggressive behavior in mice","volume":"20","author":"Beeman","year":"1947","journal-title":"Physiol. Zool."},{"key":"10.1016\/j.bbi.2017.04.023_b0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002620000120","article-title":"Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors","volume":"49","author":"Bergman","year":"2000","journal-title":"Cancer Immunol., Immunother.: CII"},{"key":"10.1016\/j.bbi.2017.04.023_b0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.42.4.522","article-title":"Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract","volume":"42","author":"Berstad","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.bbi.2017.04.023_b0030","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1172\/JCI119638","article-title":"Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity","volume":"100","author":"Brasoveanu","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbi.2017.04.023_b0035","doi-asserted-by":"crossref","first-page":"35850","DOI":"10.1074\/jbc.M109.071670","article-title":"Live cell analysis of aquaporin-4 m1\/m23 interactions and regulated orthogonal array assembly in glial cells","volume":"284","author":"Crane","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2017.04.023_b0040","doi-asserted-by":"crossref","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","article-title":"Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1\/M23 isoforms and orthogonal arrays","volume":"286","author":"Crane","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2017.04.023_b0045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaneurol.2014.775","article-title":"Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum","volume":"71","author":"Guo","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2017.04.023_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2567.2003.01628.x","article-title":"Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison","volume":"109","author":"Harris","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2017.04.023_b0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/B978-0-444-63432-0.00021-9","article-title":"Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders","volume":"133","author":"Hinson","year":"2016","journal-title":"Handbook Clin. Neurol."},{"key":"10.1016\/j.bbi.2017.04.023_b0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4049\/jimmunol.0902278","article-title":"A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1\/AIDS","volume":"184","author":"Hu","year":"2010","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.bbi.2017.04.023_b0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2017.04.023_b0070","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/db12-0570","article-title":"Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-delta activation","volume":"62","author":"Li","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbi.2017.04.023_b0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/mus.24298","article-title":"Transient hyperckemia in the setting of neuromyelitis optica (NMO)","volume":"50","author":"Malik","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbi.2017.04.023_b0080","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaneurol.2013.3124","article-title":"Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica","volume":"70","author":"Matiello","year":"2013","journal-title":"JAMA Neurol."},{"issue":"Pt 3","key":"10.1016\/j.bbi.2017.04.023_b0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1042\/bj3160923","article-title":"Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis","volume":"316","author":"Meri","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbi.2017.04.023_b0090","first-page":"532","article-title":"Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues","volume":"65","author":"Meri","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbi.2017.04.023_b0095","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2017.04.023_b0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1097-4598(199701)20:1<92::AID-MUS12>3.0.CO;2-3","article-title":"Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers","volume":"20","author":"Navenot","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbi.2017.04.023_b0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-1759(89)90088-4","article-title":"Mouse strains with typical mammalian levels of complement activity","volume":"125","author":"Ong","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbi.2017.04.023_b0110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2017.04.023_b0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2017.04.023_b0120","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","article-title":"Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays","volume":"287","author":"Phuan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2017.04.023_b0125","doi-asserted-by":"crossref","first-page":"e27412","DOI":"10.1371\/journal.pone.0027412","article-title":"Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema","volume":"6","author":"Ratelade","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2017.04.023_b0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2014.06.003","article-title":"Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica","volume":"62","author":"Ratelade","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbi.2017.04.023_b0135","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.144.9.3478","article-title":"The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b\u20139","volume":"144","author":"Rollins","year":"1990","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.bbi.2017.04.023_b0140","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/1352458515571446","article-title":"Role of membrane complement regulators in neuromyelitis optica","volume":"21","author":"Saadoun","year":"2015","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"key":"10.1016\/j.bbi.2017.04.023_b0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2017.04.023_b0150","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2017.04.023_b0155","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1600135","article-title":"CFHR1-modified neural stem cells ameliorated brain injury in a mouse model of neuromyelitis optica spectrum disorders","author":"Shi","year":"2016","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.bbi.2017.04.023_b0160","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2017.04.023_b0165","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1164\/ajrccm.152.3.7545058","article-title":"Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract","volume":"152","author":"Varsano","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbi.2017.04.023_b0170","first-page":"542","article-title":"The expression of CD59 in normal human nervous tissue","volume":"82","author":"Vedeler","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2017.04.023_b0175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd4226","article-title":"Aquaporins: important but elusive drug targets","volume":"13","author":"Verkman","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bbi.2017.04.023_b0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2017.04.023_b0185","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/mt.2012.12","article-title":"CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes","volume":"20","author":"Yan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbi.2017.04.023_b0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","article-title":"Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59","volume":"53","author":"Zhang","year":"2014","journal-title":"J. Autoimmun."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117301411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117301411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:45:12Z","timestamp":1760168712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159117301411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":38,"alternative-id":["S0889159117301411"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.04.023","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}